Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients

Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12882-016-0256-0

DC Field	Value
dc.title	Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
dc.contributor.author	Nguyen H.V.
dc.contributor.author	Bose S.
dc.contributor.author	Finkelstein E.
dc.date.accessioned	2018-06-25T02:06:59Z
dc.date.available	2018-06-25T02:06:59Z
dc.date.issued	2016
dc.identifier.citation	Nguyen H.V., Bose S., Finkelstein E. (2016). Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients. BMC Nephrology 17 (1) : 256. ScholarBank@NUS Repository. https://doi.org/10.1186/s12882-016-0256-0
dc.identifier.issn	1471-2369
dc.identifier.uri	http://scholarbank.nus.edu.sg/handle/10635/143488
dc.publisher	BioMed Central Ltd.
dc.source	Scopus
dc.type	Article
dc.contributor.department	DUKE-NUS MEDICAL SCHOOL
dc.description.doi	10.1186/s12882-016-0256-0
dc.description.sourcetitle	BMC Nephrology
dc.description.volume	17
dc.description.issue	1
dc.description.page	256
dc.identifier.isiut	000374925300001
dc.published.state	published
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
s12882-016-0256-0.pdf		912.67 kB	Adobe PDF	OPEN	None	View/Download

Check